Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing

PURPOSE: In 2018, Medicare issued a national coverage determination (NCD) providing reimbursement for next-generation sequencing (NGS) tests for beneficiaries with advanced or metastatic cancer and no previous NGS testing. We examined the association between NCD implementation and NGS utilization tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheinson, Daniel M., Wong, William B., Flores, Carlos, Ogale, Sarika, Gross, Cary P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL CONTRIBUTIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600504/
https://www.ncbi.nlm.nih.gov/pubmed/34043456
http://dx.doi.org/10.1200/OP.20.01023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600504/
https://www.ncbi.nlm.nih.gov/pubmed/34043456
http://dx.doi.org/10.1200/OP.20.01023

Ejemplares similares